Works matching IS 1567567X AND DT 2025 AND VI 52 AND IP 2
Results: 6
Sampling from covariate distribution may not always be necessary in PK/PD simulations: illustrative examples with antibiotics.
- Published in:
- Journal of Pharmacokinetics & Pharmacodynamics, 2025, v. 52, n. 2, p. 1, doi. 10.1007/s10928-025-09967-6
- By:
- Publication type:
- Article
The impact of misspecified covariate models on inclusion and omission bias when using fixed effects and full random effects models.
- Published in:
- Journal of Pharmacokinetics & Pharmacodynamics, 2025, v. 52, n. 2, p. 1, doi. 10.1007/s10928-025-09964-9
- By:
- Publication type:
- Article
The impact of misspecified covariate models on inclusion and omission bias when using fixed effects and full random effects models.
- Published in:
- Journal of Pharmacokinetics & Pharmacodynamics, 2025, v. 52, n. 2, p. 1, doi. 10.1007/s10928-025-09964-9
- By:
- Publication type:
- Article
Defining preclinical efficacy with the DNAPK inhibitor AZD7648 in combination with olaparib: a minimal systems pharmacokinetic–pharmacodynamic model.
- Published in:
- Journal of Pharmacokinetics & Pharmacodynamics, 2025, v. 52, n. 2, p. 1, doi. 10.1007/s10928-025-09962-x
- By:
- Publication type:
- Article
Defining preclinical efficacy with the DNAPK inhibitor AZD7648 in combination with olaparib: a minimal systems pharmacokinetic–pharmacodynamic model.
- Published in:
- Journal of Pharmacokinetics & Pharmacodynamics, 2025, v. 52, n. 2, p. 1, doi. 10.1007/s10928-025-09962-x
- By:
- Publication type:
- Article
Reliability of in vitro data for the mechanistic prediction of brain extracellular fluid pharmacokinetics of P-glycoprotein substrates in vivo; are we scaling correctly?
- Published in:
- Journal of Pharmacokinetics & Pharmacodynamics, 2025, v. 52, n. 2, p. 1, doi. 10.1007/s10928-025-09963-w
- By:
- Publication type:
- Article